Advertisement
Screener

SELLAS Life Sciences Group, Inc. (SLS) Graph

SLS Revenue Flow

Filed revenue amounts for 2026-01-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue (m); Cost of revenue (m); Research and development (m); Selling, general and administrative (m).
  • 2026-03-31: Revenue (m); Cost of revenue $0.00; Research and development (m); Selling, general and administrative (m).
  • 2025-12-31: Revenue (m); Cost of revenue $0.00*; Research and development (m); Selling, general and administrative $3.52M*.
  • 2025-09-30: Revenue (m); Cost of revenue $0.00; Research and development (m); Selling, general and administrative $2.87M.

Revenue flow

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

SLS revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Revenue$0.00Cost of revenue$0.00Operating income-$19.88M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30(m)(m)(m)(m)(m)(m)-$9.61M
2026-03-31(m)$0.00(m)(m)(m)(m)-$8.41M
2025-12-31(m)$0.00*(m)$3.52M*(m)(m)-$7.66M*
2025-09-30(m)$0.00(m)$2.87M(m)(m)-$6.79M
2025-06-30(m)$0.00(m)$3.00M(m)(m)-$6.60M
2025-03-31(m)$0.00(m)$2.86M(m)(m)-$5.81M
2024-09-30(m)$0.00(m)$2.97M(m)(m)-$7.11M
2024-06-30(m)$0.00(m)$2.44M(m)(m)-$7.47M
2024-03-31(m)$0.00(m)$4.53M(m)(m)-$9.57M
2023-12-31$0.00*(m)(m)(m)(m)(m)(m)
2023-09-30$0.00$0.00(m)$3.55M(m)(m)-$9.27M
2023-06-30$0.00$0.00(m)$3.13M(m)(m)-$8.84M
2023-03-31$0.00$0.00(m)$4.11M(m)(m)-$11.10M
2022-09-30$0.00$0.00(m)$2.86M(m)(m)-$7.02M
2022-06-30$0.00$0.00(m)$3.09M(m)(m)-$8.41M
2022-03-31$1.00M$100.00K(m)$3.02M(m)(m)-$16.74M
2021-12-31(m)(m)$3.39M*(m)(m)(m)(m)
2021-09-30$0.00$0.00$4.54M$2.44M(m)(m)-$7.08M
2021-06-30$1.90M$100.00K$3.46M$2.80M(m)(m)-$4.61M
2021-03-31$5.70M$100.00K$4.28M$3.56M(m)(m)-$2.40M
2020-09-30$0.00$0.00$2.37M$2.13M(m)(m)-$4.47M
2020-06-30$0.00$0.00$2.28M$1.99M(m)(m)-$4.42M
2020-03-31$0.00$0.00$1.86M$2.20M(m)(m)-$4.14M
2019-09-30(m)(m)$1.80M$2.38M(m)$0.00-$4.20M
2019-06-30(m)(m)$1.38M$2.64M(m)$0.00-$3.13M
2019-03-31(m)(m)$1.86M$2.50M(m)(m)-$4.54M
2018-09-30(m)(m)$1.72M$1.34M(m)$0.00-$290.00K
2018-06-30(m)(m)$1.59M$4.91M(m)$163.00K-$6.06M
2018-03-31(m)(m)$1.80M$3.88M(m)(m)-$8.00M
2017-09-30(m)(m)$1.07M$3.22M(m)$63.00K-$4.46M
2017-06-30(m)(m)$1.83M$3.84M(m)$117.00K-$5.91M
2017-03-31(m)(m)$2.18M$2.29M(m)(m)-$4.60M
2016-09-30(m)(m)$3.62M$2.85M(m)(m)-$6.93M
2016-06-30(m)(m)$6.17M$3.12M(m)(m)$5.39M
2016-03-31(m)(m)$5.44M$3.52M(m)(m)-$16.49M
2015-09-30(m)(m)$5.74M$2.90M(m)(m)-$18.03M
2015-06-30$3.38M$468.00K$7.20M$1.89M(m)(m)-$15.66M
2015-03-31$2.75M$393.00K$5.83M$3.09M(m)(m)-$10.54M
2014-12-31$3.19M*$478.00K*(m)(m)(m)(m)(m)
2014-09-30$1.62M$247.00K$7.03M$3.54M(m)$0.00-$6.17M
2014-06-30$2.33M$347.00K$8.07M$9.60M(m)$0.00-$19.94M
2014-03-31$2.17M$331.00K$6.77M$6.83M(m)$0.00-$2.54M
2013-12-31$1.44M(m)(m)(m)(m)(m)-$5.52M
2013-09-30$2.17M$258.00K$3.63M$4.13M$7.76M$1.16M-$6.93M
2013-06-30$3.38M$0.00$5.28M$2.71M$7.99M$1.54M$5.39M
2013-03-31$2.75M$0.00$5.08M$1.53M$6.61M-$2.76M-$16.49M
2012-12-31$1.44M(m)(m)(m)(m)(m)-$19.68M
2012-09-30$2.17M$0.00$4.17M(m)$5.53M(m)-$18.03M
2012-06-30$3.38M(m)$3.72M(m)$5.68M(m)-$15.66M
2012-03-31$2.75M(m)$2.66M(m)$4.41M(m)-$10.54M
2011-09-30(m)(m)$1.37M(m)$3.44M(m)-$5.47M
2011-06-30(m)(m)$329.00K(m)$2.28M(m)-$3.75M
2011-03-31(m)(m)$2.16M(m)$5.28M(m)-$3.84M
2010-09-30(m)(m)$1.94M(m)$3.72M(m)-$4.13M
2010-06-30(m)(m)$2.26M(m)$4.75M(m)-$2.14M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$0.00$0.00(m)(m)(m)(m)-$18.01M
2025-06-30$0.00$0.00(m)$5.86M(m)(m)-$12.41M
2024-06-30(m)$0.00(m)$6.97M(m)(m)-$17.04M
2023-06-30$0.00$0.00(m)$7.23M(m)(m)-$19.94M
2022-06-30$1.00M$100.00K(m)$6.12M(m)(m)-$25.16M
2021-06-30$7.60M$200.00K$7.74M$6.36M(m)(m)-$7.02M
2020-06-30$0.00$0.00$4.14M$4.19M(m)(m)-$8.57M
2019-06-30(m)(m)$3.24M$5.14M(m)$0.00-$7.67M
2018-06-30(m)(m)$3.40M$8.79M(m)$163.00K-$14.06M
2017-06-30(m)(m)$4.01M$6.13M(m)$117.00K-$10.51M
2016-06-30(m)(m)$11.62M$6.64M(m)(m)-$11.10M
2015-06-30$6.13M$861.00K$13.02M$4.97M(m)(m)-$26.20M
2014-06-30$4.50M$678.00K$14.84M$16.43M(m)$0.00-$22.48M
2013-06-30$0.00$0.00$10.36M$4.24M$14.60M-$1.22M-$18.89M
2012-06-30(m)(m)$6.38M(m)$10.09M(m)-$24.96M
2011-06-30(m)(m)$390.00K(m)$5.46M(m)-$7.60M
2010-06-30(m)(m)$4.19M(m)$9.21M(m)-$6.03M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30(m)$0.00(m)$8.73M(m)(m)-$19.20M
2024-09-30(m)$0.00(m)$9.94M(m)(m)-$24.14M
2023-09-30$0.00$0.00(m)$10.78M(m)(m)-$29.20M
2022-09-30$1.00M$100.00K(m)$8.98M(m)(m)-$32.18M
2021-09-30$7.60M$200.00K$12.28M$8.79M(m)(m)-$14.10M
2020-09-30$0.00$0.00$6.51M$6.31M(m)(m)-$13.04M
2019-09-30(m)(m)$5.04M$7.52M(m)$0.00-$11.87M
2018-09-30(m)(m)$5.12M$10.13M(m)$163.00K-$14.35M
2017-09-30(m)(m)$5.08M$9.35M(m)$180.00K-$14.97M
2016-09-30(m)(m)$15.24M$9.49M(m)(m)-$18.03M
2015-09-30(m)(m)$18.76M$7.87M(m)(m)-$44.22M
2014-09-30$6.12M$925.00K$21.46M$12.74M(m)$0.00-$28.65M
2013-09-30$1.17M$258.00K$13.99M$8.37M$22.36M-$62.00K-$28.18M
2012-09-30$0.00$0.00$10.55M(m)$15.62M(m)-$31.22M
2011-09-30(m)(m)$1.76M(m)$8.89M(m)-$13.07M
2010-09-30(m)(m)$6.13M(m)$12.93M(m)-$10.16M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31(m)$0.00(m)$12.25M(m)$0.00-$26.86M
2024-12-31(m)$0.00(m)$12.42M(m)$0.00-$30.88M
2023-12-31$0.00$0.00(m)$13.86M(m)$0.00-$37.34M
2022-12-31$1.00M$100.00K(m)$12.58M(m)$0.00-$41.30M
2021-12-31$7.60M$200.00K$15.67M$11.32M(m)-$237.00K-$20.70M
2020-12-31$1.90M$0.00$9.28M$9.60M(m)-$17.00K-$16.76M
2019-12-31$0.00(m)$7.29M$9.92M(m)-$81.00K-$19.29M
2018-12-31(m)(m)$8.77M$12.77M(m)-$1.38M-$27.67M
2017-12-31(m)(m)$6.07M$15.09M(m)$253.00K-$23.75M
2016-12-31(m)(m)$11.39M$4.59M$31.87M$1.00K-$17.68M
2015-12-31(m)(m)(m)(m)$34.22M$365.00K-$63.90M
2014-12-31$9.32M$1.40M(m)(m)$43.90M$0.00-$36.61M
2013-12-31$2.49M$520.00K(m)(m)$28.49M$1.05M-$76.68M
2012-12-31$0.00$0.00$14.61M(m)$21.20M-$1.05M-$34.97M
2011-12-31$0.00$0.00$3.85M(m)$12.49M(m)-$11.48M
2010-12-31(m)(m)$7.87M(m)$16.63M(m)-$11.99M

Similar stocks

Stock NameCountryMarket CapPE Ratio
uniQure N.V. (QURE)$2.416B-4.93
Vera Therapeutics, Inc. (VERA)United States$2.402B-7.67
Harmony Biosciences Holdings, Inc. (HRMY)United States$2.399B11.67
Nurix Therapeutics, Inc. (NRIX)United States$2.457B-5.39
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38
SUPERNUS PHARMACEUTICALS, INC. (SUPN)United States$2.517B-24.63
Immunome Inc. (IMNM)United States$2.538B-9.45
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Zai Lab Ltd (ZLAB)$2.241B-113.34